Melatonin ameliorates Angiotensin II-induced vascular endothelial damage via its antioxidative properties

Journal of Pineal Research

Volumn 55, Issue 3, 2013, Pages 287-293

  Nakao, Tomoko ^a   Morita, Hiroyuki ^a   Maemura, Koji ^b   Amiya, Eisuke ^a   Inajima, Tsukasa ^a   Saito, Yuichiro ^c   Watanabe, Masafumi ^a   Manabe, Ichiro ^a   Kurabayashi, Masahiko ^c   Nagai, Ryozo ^a   Komuro, Issei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

endothelial cell; melatonin; nitric oxide; oxidative stress; vascular function

Indexed keywords

ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MELATONIN; RAMELTEON; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA WALL; ARTICLE; BLOOD VESSEL INJURY; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; VASCULAR ENDOTHELIAL DAMAGE; VASCULAR ENDOTHELIUM; VASCULAR RING; VASCULARIZATION;

ENDOTHELIAL CELL; MELATONIN; NITRIC OXIDE; OXIDATIVE STRESS; VASCULAR FUNCTION;

ANGIOTENSIN II; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MELATONIN; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; VASOCONSTRICTOR AGENTS;

EID: 84883742044     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12071     Document Type: Article

References (29)

1. Krauchi K, Wirz-Justice A,. Circadian clues to sleep onset mechanisms. Neuropsychopharmacology 2001; 25: 92-96.
2. Brugger P, Marktl W, Herold M,. Impaired nocturnal secretion of melatonin in coronary artery disease. Lancet 1995; 345: 1408.
3. Sakotnik A, Liebmann PM, Stoschitzky K, et al. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999; 20: 1314-1317.
4. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, et al. Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis 2008; 199: 73-78.
5. Reiter RJ, Tan DX,. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58: 10-19.
6. Petrosillo G, Di Venosa N, Pistolese M, et al. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia-reperfusion: role of cardiolipin. FASEB J 2006; 20: 269-276.
7. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, et al. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials 2007; 28: 532-539.
8. K-Laflamme A, Wu L, Foucart S, et al. Impaired basal sympathetic tone and α1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 219-229.
9. Wakatsuki A, Okatani Y, Ikenoue N, et al. Melatonin protects against oxidized low-density lipoprotein-induced inhibition of nitric oxide production in human umbilical artery. J Pineal Res 2001; 31: 281-288.
10. Reyes-Toso CF, Linares LM, Ricci CR, et al. Melatonin restores endothelium-dependent relaxation in aortic rings of pancreatectomized rats. J Pineal Res 2005; 39: 386-391.
11. Reiter RJ, Tan DX, Paredes SD, et al. Beneficial effects of melatonin in cardiovascular disease. Ann Med 2010; 42: 276-285.
12. Amiya E, Watanabe M, Takeda N, et al. Angiotensin II impairs endothelial nitric oxide synthase bioavailability under free cholesterol-enriched conditions via intracellular free cholesterol-rich membrane microdomains. J Biol Chem 2013; 288: 14497-14509.
13. Wei T, Chen C, Hou J, et al. Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta 2000; 1498: 72-79.
14. Zou AP, Li N, Cowley AW Jr,. Production and actions of superoxide in the renal medulla. Hypertension 2001; 37: 547-553.
15. Isshiki K, Haneda M, Koya D, et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of insulin-sensitizing action in diabetic rats. Diabetes 2000; 49: 1022-1032.
16. Morita H, Saito Y, Ohashi N, et al. Fluvastatin ameliorates the hyperhomocysteinemia-induced endothelial dysfunction: the antioxidative properties of fluvastatin. Circ J 2005; 69: 475-480.
17. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
18. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
19. Zuo L, Ushio-Fukai M, Ikeda S, et al. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 2005; 25: 1824-1830.
20. Pueyo ME, Gonzalez W, Nicoletti A, et al. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20: 645-651.
21. Griendling KK, Sorescu D, Ushio-Fukai M,. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
22. 1-42. J Pineal Res 2008; 45: 157-165.
23. Kato K, Hirai K, Nishiyama K, et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 2005; 48: 301-310.
24. Barlow-Walden LR, Reiter RJ, Abe M, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995; 26: 497-502.
25. Pablos MI, Reiter RJ, Ortiz GG, et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem Int 1998; 32: 69-75.
26. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
27. Allegra M, Reiter RJ, Tan DX, et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34: 1-10.
28. Leon J, Acuña-Castroviejo D, Sainz RM, et al. Melatonin and mitochondrial function. Life Sci 2004; 75: 765-790.
29. Sallinen P, Mänttäri S, Leskinen H, et al. The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin. J Pineal Res 2007; 42: 254-260.